Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 juin 2026 13h00 HE | Source: DelveInsight Business Research LLP

IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight

New York, USA, June 25, 2026 (GLOBE NEWSWIRE) -- IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight The IgA nephropathy clinical trial analysis...
14 déc. 2022 13h00 HE | Source: DelveInsight Business Research LLP

IgA Nephropathy Clinical Trials Pipeline Analysis: 30+ Companies are Working to Improve the Treatment Space | DelveInsight

New York, USA, Dec. 14, 2022 (GLOBE NEWSWIRE) -- IgA Nephropathy Clinical Trials Pipeline Analysis: 30+ Companies are Working to Improve the Treatment Space | DelveInsight DelveInsight’s IgA...
30 oct. 2018 02h35 HE | Source: Prescient & Strategic Intelligence

IgA Nephropathy Therapeutics Pipeline is Witnessing Significant Growth Due to Unavailability of Specific Treatment: P&S Intelligence

Immunoglobulin A (IgA) Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, Patient Size, and Epidemiology Forecast to 2025 NEW YORK,...